N
1752
vs
LLY
N
1752
LLY
Over the past 12 months, Nang Kuang Pharmaceutical Co Ltd has underperformed LLY, delivering a return of +2% compared to the LLY's +13% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
1752
LLY
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
N
Intrinsic Value
41.13
TWD
Undervaluation 13%
LLY
Intrinsic Value
596.97
USD
Overvaluation 36%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
N
|
Nang Kuang Pharmaceutical Co Ltd
TWSE:1752
|
35.6
TWD
|
|||||
|
Eli Lilly and Co
NYSE:LLY
|
927.03
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
1752, LLY
1752, LLY
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
N
|
Nang Kuang Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
|
Eli Lilly and Co
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
1752, LLY
1752, LLY
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
N
|
Nang Kuang Pharmaceutical Co Ltd
TWSE:1752
|
|||||||||
|
|
Eli Lilly and Co
NYSE:LLY
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Nang Kuang Pharmaceutical Co Ltd
35.6%
LLY
83%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
Nang Kuang Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
Operating Margin
Nang Kuang Pharmaceutical Co Ltd
13.7%
LLY
45.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
Nang Kuang Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
Net Margin
Nang Kuang Pharmaceutical Co Ltd
11.3%
LLY
31.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
Nang Kuang Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
FCF Margin
Nang Kuang Pharmaceutical Co Ltd
8.5%
LLY
9.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
Nang Kuang Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROE
Nang Kuang Pharmaceutical Co Ltd
10%
LLY
101.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
Nang Kuang Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROA
Nang Kuang Pharmaceutical Co Ltd
6.4%
LLY
21.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
Nang Kuang Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROIC
Nang Kuang Pharmaceutical Co Ltd
7.6%
LLY
27.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
Nang Kuang Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROCE
Nang Kuang Pharmaceutical Co Ltd
10.9%
LLY
46.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
N
|
Nang Kuang Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
Solvency Comparison
N
Nang Kuang Pharmaceutical Co Ltd
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
1752, LLY
1752, LLY
Performance By Year
1752, LLY
1752, LLY
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 1752 to other stocks
JNJ
Johnson & Johnson
More expensive
vs Nang Kuang Pharmaceutical Co L...
AZN
AstraZeneca PLC
More expensive
vs Nang Kuang Pharmaceutical Co L...
ROG
Roche Holding AG
Cheaper
vs Nang Kuang Pharmaceutical Co L...
NOVN
Novartis AG
More expensive
vs Nang Kuang Pharmaceutical Co L...
Select Stock to Compare
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
